Curatis Holding AG (CHIX:CURNZ) Debt-to-Equity : -0.43 (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Curatis Holding AG Debt-to-Equity?

Curatis Holding AG's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was CHF0.00 Mil. Curatis Holding AG's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was CHF0.13 Mil. Curatis Holding AG's Total Stockholders Equity for the quarter that ended in Dec. 2023 was CHF-0.31 Mil. Curatis Holding AG's debt to equity for the quarter that ended in Dec. 2023 was -0.43.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Curatis Holding AG's Debt-to-Equity or its related term are showing as below:

CHIX:CURNz' s Debt-to-Equity Range Over the Past 10 Years
Min: -1.07 Med: -0.43 Max: 0.44
Current: -0.43

During the past 3 years, the highest Debt-to-Equity Ratio of Curatis Holding AG was 0.44. The lowest was -1.07. And the median was -0.43.

CHIX:CURNz's Debt-to-Equity is not ranked
in the Drug Manufacturers industry.
Industry Median: 0.3 vs CHIX:CURNz: -0.43

Curatis Holding AG Debt-to-Equity Historical Data

The historical data trend for Curatis Holding AG's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curatis Holding AG Debt-to-Equity Chart

Curatis Holding AG Annual Data

Trend

Dec21

Dec22

Dec23

Debt-to-Equity

-1.07

0.44

-0.43

Curatis Holding AG Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial			-1.07	0.09	0.44	0.48	-0.43

Competitive Comparison of Curatis Holding AG's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Curatis Holding AG's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Curatis Holding AG's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Curatis Holding AG's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Curatis Holding AG's Debt-to-Equity falls into.

Curatis Holding AG Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Curatis Holding AG's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0.133)	/	-0.312
	=	-0.43

Curatis Holding AG's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0.133)	/	-0.312
	=	-0.43

Curatis Holding AG (CHIX:CURNz) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Curatis Holding AG Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Curatis Holding AG's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Curatis Holding AG (CHIX:CURNZ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curatis Holding AG (CHIX:CURNz) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

CURN:Switzerland

Address

Hochbergerstrasse 60C, Technologiepark Basel, Basel, CHE, 4057

Website

https://www.kinarus.com

Kinarus Therapeutics Holding AG In Liquidation Formerly Kinarus Therapeutics Holding AG is a clinical-stage pharmaceutical company focused on bringing novel treatments to patients suffering from viral, respiratory, and ophthalmic diseases. The company's therapeutic drug candidate, KIN001, consists of a clinical-stage p38 mitogen-activated protein kinase (p38 MAPK) inhibitor, in-licensed from Roche, combined with a marketed drug, together enabling an oral, long-term effective treatment for patients suffering from diseases with serious impact on quality of life.

Curatis Holding AG (CHIX:CURNZ) Headlines

No Headlines